Search Results
Mar 17, 2026, 14:00 ET Health Care Organizations Press Congress to End MPPR Policy|
reduction significantly undervalues therapy services and ignores the distinct scopes and resource demands of PT, OT, and SLP. Further, the MPPR policy does not recognize that OT, PT, and SLP interventions are separate and distinct from one another. This disproportionately affects beneficiaries with complex
More news about: American Physical Therapy Association
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México
anti-CD20. Os pacientes foram randomizados para receber tafasitamabe + R2 (n = 273) versus placebo + R2 (n = 275). A sobrevida livre de progressão (SLP; desfecho primário) mediana estimada foi de 22,37 meses (IC 95%: 19,22, NE) no grupo tafasitamabe + R2, comparado com 13,93 meses (IC 95%: 11,53, 16,39)
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la presentación regulatoria complementaria de MINJUVI® (tafasitamab) para linfoma folicular en Argentina y México
anti-CD20. Los pacientes fueron aleatorizados para recibir tafasitamab + R2 (n = 273) versus placebo + R2 (n = 275). La supervivencia libre de progresión (SLP; criterio principal) mediana estimada fue de 22,37 meses (IC 95%: 19,22, NE) en el grupo tafasitamab + R2, en comparación con 13,93 meses (IC 95%: 11,53,
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil
anti-CD20. Os pacientes foram randomizados para receber tafasitamabe + R2 (n = 273) versus placebo + R2 (n = 275). A sobrevida livre de progressão (SLP; desfecho primário) mediana estimada foi de 22,37 meses (IC 95%: 19,22, NE) no grupo tafasitamabe + R2, comparado com 13,93 meses (IC 95%: 11,53, 16,39)
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la aprobación de una indicación adicional para MINJUVI® (tafasitamab) en Brasil
anti-CD20. Los pacientes fueron aleatorizados para recibir tafasitamab + R2 (n = 273) versus placebo + R2 (n = 275). La supervivencia libre de progresión (SLP; criterio principal) mediana estimada fue de 22,37 meses (IC 95%: 19,22, NE) en el grupo tafasitamab + R2, en comparación con 13,93 meses (IC 95%: 11,53,
More news about: Knight Therapeutics Inc.
Mar 16, 2026, 10:20 ET Laronix Launches Voice Restoration Study for ICU Patients at Greater Baltimore Medical Center
results in a considerable amount of time being spent by our clinicians trying to understand and communicate with patients," said Bushra Lohrasbi, MA, CCC-SLP, speech-language pathologist with the Milton J. Dance Center at GBMC and the study's primary investigator. "Technological advances, such as MIRA Voice,
More news about: Laronix, Inc.
Feb 25, 2026, 14:30 ET Senior Lifestyle Executive Bob Gawronski Elected President of Affordable Assisted Living Coalition
works to advance the Illinois Supportive Living Program (SLP), which gives seniors and persons with physical disabilities an affordable, quality alternative to nursing home care. As a non-profit-membership organization representing more than 160 SLP communities and service-providers, AALC is the leading
More news about: Senior Lifestyle
Feb 24, 2026, 17:04 ET National Event Series "Parkinson's IQ + You" Arrives in Southern Nevada to Educate and Empower Parkinson's Disease Patients and Care Partners
specialist at Keck Medicine of USC; Dr. Katie Nathan, physical therapist at Moved by Movement; and speech language pathologist, Linda L. Ganz, MS, CCC-SLP at the Vegas Voice Institute. "Exploring the Latest in Parkinson's Research," led by Maggie Kuhl, MJFF's vice president
More news about: The Michael J. Fox Foundation for Parkinson's Research
Feb 24, 2026, 07:05 ET Hearing Loss in Children: ASHA, EAA Stress Importance of Prevention and Early Intervention This World Hearing Day
2026 ASHA President Linda I. Rosa-Lugo, EdD, CCC-SLP, ASHA Fellow. "One important step is teaching kids of all ages to turn the volume down on their electronic devices. Noise-induced hearing loss is becoming
More news about: American Speech-Language-Hearing Association (ASHA)
Feb 10, 2026, 08:07 ET Blackbird Health Opens New Centreville Clinic to Expand Access to Pediatric Mental Health Care in Northern Virginia
20120 at the juncture of I-66, Lee Highway, and 28, the clinic offers in-person and virtual care, including comprehensive evaluations for ADHD, ASD, SLP, and OT, therapeutic services, and medication management. Appointments are now available; families can reach the clinic at (703) 239-3470 or learn
More news about: Blackbird Health Inc.
Feb 08, 2026, 12:51 ET Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.So What:
More news about: THE ROSEN LAW FIRM, P. A.
Feb 03, 2026, 17:30 ET Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.So What:
More news about: THE ROSEN LAW FIRM, P. A.
Jan 29, 2026, 22:00 ET Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.So What:
More news about: THE ROSEN LAW FIRM, P. A.
Jan 23, 2026, 15:22 ET Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.So What:
More news about: THE ROSEN LAW FIRM, P. A.
Jan 21, 2026, 09:15 ET Point Quest Group Strengthens National Role as a Holistic Special Education Partner
invest in deepening early intervention and mental health services, expanding its expert clinical bench across behavioral health, mental health, OT, PT, SLP, and teletherapy, and improving outcomes measurement and reporting for its school partners.About Point Quest Group
More news about: Point Quest Group
Jan 08, 2026, 08:03 ET Lennox Launches Gas Furnace Featuring Integrated Refrigerant Detection System
comfort solutions, announced today the release of the Dave Lennox Signature® SLP99VK Gas Furnace, designed to deliver high-efficiency heating with built-in refrigerant detection capability.The SLP99VK is integrated with a Refrigerant Detection System (RDS), eliminating the need for a
More news about: Lennox International Inc.
Dec 19, 2025, 21:08 ET WebPT Announces Advocate Physical Therapy & Tilton's Therapy as Winners of the 2025 Ascend Awards
TherapyTilton's Therapy was honored for redefining access to care across Nevada through a statewide mobile therapy model that delivers PT, OT, and SLP in homes, schools, community sites, and wherever patients are. This approach integrates behavioral health, caregiver mental health, and justice-involved
More news about: WebPT
Dec 10, 2025, 14:16 ET Menarini Group apresenta os dados da fase 2 da combinação de elacestranto (ORSERDU®) em pacientes com câncer de mama metastático (mBC) ER+, HER2- no San Antonio Breast Cancer Symposium 2025 (SABCS)
ELEVATE a serem apresentados no SABCS demonstram que o elacestranto em combinação com everolimo ou com abemaciclibe mostra um benefício consistente na SLP, independentemente do status da mutação ESR1 em pacientes com mBC ER+/HER2-, que apresentam progressão da doença em terapia endócrina (ET), com
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 11:38 ET El Grupo Menarini presenta datos de la combinación de fase 2 de Elacestrant (ORSERDU®) en cáncer de mama
innovadores a pacientes con cáncer, presentarán resultados actualizados y significativos de la eficacia de la mediana de supervivencia libre de progresión (SLP) de dos regímenes combinados del estudio de fase 2 ELEVATE en pacientes con cáncer de mama localmente avanzado o metastásico (CMM) con receptor de estrógeno
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 10:12 ET Automotive PCB Market to Reach USD 11.91 Billion by 2030, Driven by EV and ADAS Growth | Valuates Reports
Substrate-like PCB (SLP) Market was valued at USD 2854 Million in the year 2024 and is projected to reach a revised size of USD 3716 Million by 2031, growing at a CAGR
More news about: Valuates Reports
Nov 28, 2025, 15:10 ET INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Simulations Plus, Inc. (NASDAQ: SLP) and Encourages Investors with Substantial Losses to Contact the Firm
/PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Simulations Plus, Inc. (NASDAQ: SLP), resulting from allegations of providing potentially misleading business information to the investing public.
More news about: Edelson Lechtzin LLP
Nov 21, 2025, 06:22 ET Weekly Recap: 14 Health Press Releases You Need to See
connection is what the holidays are all about," says American Speech-Language-Hearing Association 2025 President Bernadette Mayfield-Clarke, PhD, CCC-SLP. "By modifying how you approach a loved one who is dealing with the disease, family and friends can communicate more effectively and have more fulfilling
More news about: PR Newswire
Nov 20, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Simulations Plus, Inc. - SLP
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ: SLP). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Nov 18, 2025, 06:48 ET Home for the Holidays: Experts Share Tips for Communicating and Connecting When a Loved One Has Dementia
Bernadette Mayfield-Clarke, PhD, CCC-SLP. "By modifying how you approach a loved one who is dealing with the disease, family and friends can communicate more effectively and have more fulfilling
More news about: American Speech-Language-Hearing Association (ASHA)
Nov 12, 2025, 10:15 ET SpeechLP Launches AI Speech Therapy App at ASHA 2025 Conference
collaboration with practicing speech-language pathologists, ensuring that every game and exercise aligns with best practices in therapy. Sarah Fleischman, SLP and SpeechLP advisor, shared, "Families and clinicians face limited resources and repetitive exercises that can be hard to sustain. With SpeechLP, children
More news about: SpeechLP